What's breaking now, across thousands of outlets.
(MedPage Today) -- On September 9, the 5th Circuit Court of Appeals heard oral arguments in Louisiana et al. v. FDA et al., a case challenging the FDA's regulation of mifepristone (Mifeprex). Mifepristone is a highly safe and effective prescription...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
A new study of nearly 4,000 older adults reveals that daily variations in the stress hormone cortisol predict cognitive decline.
Injectable weight-loss treatments are becoming increasingly popular in the Philippines but health experts are warning Filipinos against self-medication and purchasing unregistered or compounded…
The Lagos State Consumer Protection Agency has raised the alarm over increasingly sophisticated adulteration of palm oil, urging residents to be vigilant when purchasing the widely consumed product.
The Trump administration is rolling out a new model that aims to bring most-favored nation pricing to the Medicaid space.
The "most favored nation" drug pricing deals that Pfizer and Eli Lilly signed with the Trump administration suggest the companies will give the government a share of increased revenue they generate…
CVS Health's Omnicare unit has started voluntary Chapter 11 bankruptcy proceedings as it navigates a series of legal challenges.
